Hers vs Luvo Health: Which GLP-1 Provider Is Better?
Short answer: Hers scores higher on our rubric, 5.3/10 against 2.4/10. Full reasoning, pricing and the cases where the other one wins are below.
Hers beats Luvo Health overall, scoring 5.3/10 vs 2.4/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Luvo Health is from $249/mo. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose Luvo Health for people who want compounded semaglutide or tirzepatide alongside longevity, nad or hormone care from one clinic, and who will do the 4-week-cycle arithmetic before committing.
A side-by-side look at Hers and Luvo Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#45 of 53The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersLuvo Health
#53 of 53Luvo Health is a multi-service telehealth clinic running weight loss beside microdosing, longevity, skincare, hormone replacement and testosterone. Its GLP-1 line covers compounded semaglutide and tirzepatide injections, compounded semaglutide tablets, and brand Ozempic and Zepbound, each with its own page and published price. Pricing is quoted per week and billed in 4-week cycles, which reads cheaper than the monthly figure it works out to, and the brand rates are among the highest we track.
Visit Luvo Health| Feature | Hers | Luvo Health |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | Six services from one clinic, with a dedicated microdosing line that has its own products rather than a smaller dose of the main one. |
| Our Score | 5.3/10 | 2.4/10 |
| Headline Price | $188 first month, then $298/mo | from $249/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | People who want compounded semaglutide or tirzepatide alongside longevity, NAD or hormone care from one clinic, and who will do the 4-week-cycle arithmetic before committing |
| Watch out for | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. | Brand pricing is the highest we track: Ozempic $1,299 per 4 weeks ($325/week) and Zepbound $350/week, roughly $1,408/mo against NovoCare self-pay at $349 |
| Ranking | #45 | #53 |
| Get started | Visit Hers | Visit Luvo Health |
Pros & Cons Compared
Hers
Pros
- +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Luvo Health
Pros
- +Publishes a price on every medication page and a full 4-week grid on /pricing, with no intake required to see either
- +Three compounded formats including oral semaglutide tablets, plus a dedicated microdosing line with its own products
- +Cancel any time, with a published refund policy
- +Claims no accreditation it cannot support, which is rarer than it should be
- +Will transfer your prescription to any licensed pharmacy you choose, in writing, and coordinates it for you. Most compounded programs we track lock you to their own pharmacy
Cons
- −Brand pricing is the highest we track: Ozempic $1,299 per 4 weeks ($325/week) and Zepbound $350/week, roughly $1,408/mo against NovoCare self-pay at $349
- −Prices are quoted per WEEK and billed per 4-WEEK cycle, so a year is 13 cycles rather than 12 and costs more than the monthly reading suggests
- −The cheaper per-week floors ($45 semaglutide, $67 tirzepatide) require longer commitments whose terms and totals are never published
- −No medical director, prescribing clinician or medical group is named anywhere
- −No compounding pharmacy is named; 'prepared by licensed pharmacies' is as specific as the site gets
- −No legal entity is disclosed on the homepage, pricing page or FAQ
- −No lab panel is offered or required, and no third-party review profile could be located
Our Verdict
Hers edges out Luvo Health with a score of 5.3/10 vs 2.4/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Luvo Health is from $249/mo.
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both Hers and Luvo Health start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hers and Luvo Health.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Hers and Henry Medsfrom $199/mo
- Compare Hers and Ivim Healthfrom $150/mo
- Compare Hers and Calibratepublished $199/mo; total not verified
- Compare Luvo Health and AgelessRxfrom $199/mo + $50/mo clinical oversight
- Compare Luvo Health and TMatesfrom $158/mo
- Compare Luvo Health and Care Bare Rxfrom $199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit, with the verification evidence behind each answer.
Our pick of these two: Hers · 5.3/10